{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:10:35Z","timestamp":1791310235526,"version":"4.3.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T00:00:00Z","timestamp":1499472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T00:00:00Z","timestamp":1499472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL105324 and HD067541-06"],"award-info":[{"award-number":["HL105324 and HD067541-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11906-017-0757-7","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T05:57:45Z","timestamp":1499493465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":225,"title":["Pathophysiology and Current Clinical Management of Preeclampsia"],"prefix":"10.1007","volume":"19","author":[{"given":"Lorena M.","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedra","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babbette","family":"LaMarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,8]]},"reference":[{"key":"757_CR1","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 American College of O, Gynecologists, Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstetrics and gynecology. 2013;122(5):1122\u201331. doi:\n                      10.1097\/01.AOG.0000437382.03963.88\n                      \n                    . This report highlights recommendations and guidelines for the management of patients with hypertension during and after pregnancy.","DOI":"10.1097\/01.AOG.0000437382.03963.88"},{"key":"757_CR2","unstructured":"Creasy RK, Resnik R, Greene MF, Iams JD, Lockwood CJ. Creasy and Resnik\u2019s maternal-fetal medicine: principles and practice. Seventh edition ed."},{"issue":"7","key":"757_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1471-0528.1992.tb13818.x","volume":"99","author":"L Duley","year":"1992","unstructured":"Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99(7):547\u201353.","journal-title":"Br J Obstet Gynaecol"},{"key":"757_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1172\/JCI4106","volume":"103","author":"G Wallukat","year":"1999","unstructured":"Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Investig. 1999;103:945\u201352.","journal-title":"J Clin Investig"},{"issue":"3","key":"757_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009;33(3):130\u20137. doi:\n                      10.1053\/j.semperi.2009.02.010\n                      \n                    .","journal-title":"Semin Perinatol"},{"issue":"9516","key":"757_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","volume":"367","author":"KS Khan","year":"2006","unstructured":"Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066\u201374. doi:\n                      10.1016\/S0140-6736(06)68397-9\n                      \n                    .","journal-title":"Lancet"},{"issue":"3","key":"757_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1600-0897.1997.tb00222.x","volume":"37","author":"KP Conrad","year":"1997","unstructured":"Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol. 1997;37(3):240\u20139.","journal-title":"Am J Reprod Immunol"},{"issue":"2","key":"757_CR8","doi-asserted-by":"publisher","first-page":"H541","DOI":"10.1152\/ajpheart.01113.2007","volume":"294","author":"JS Gilbert","year":"2008","unstructured":"Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541\u201350. doi:\n                      10.1152\/ajpheart.01113.2007\n                      \n                    .","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"757_CR9","first-page":"105","volume":"62","author":"B Lamarca","year":"2010","unstructured":"Lamarca B. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol. 2010;62(2):105\u201320.","journal-title":"Minerva Ginecol"},{"issue":"2","key":"757_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1447-0756.2009.01128.x","volume":"36","author":"K Matsubara","year":"2010","unstructured":"Matsubara K, Matsubara Y, Hyodo S, Katayama T, Ito M. Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res. 2010;36(2):239\u201347. doi:\n                      10.1111\/j.1447-0756.2009.01128.x\n                      \n                    .","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"757_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpneph0035","volume":"1","author":"M Noris","year":"2005","unstructured":"Noris M, Perico N, Remuzzi G. Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol. 2005;1(2):98\u2013114; quiz 20. doi:\n                      10.1038\/ncpneph0035\n                      \n                    .","journal-title":"Nat Clin Pract Nephrol"},{"issue":"5728","key":"757_CR12","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","volume":"308","author":"CW Redman","year":"2005","unstructured":"Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592\u20134. doi:\n                      10.1126\/science.1111726\n                      \n                    .","journal-title":"Science"},{"issue":"3","key":"757_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2010.05.012","volume":"49","author":"VC Sandrim","year":"2010","unstructured":"Sandrim VC, Montenegro MF, Palei AC, Metzger IF, Sertorio JT, Cavalli RC, et al. Increased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsia. Free Radic Biol Med. 2010;49(3):493\u2013500. doi:\n                      10.1016\/j.freeradbiomed.2010.05.012\n                      \n                    .","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"757_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/jhh.2011.65","volume":"26","author":"LM Amaral","year":"2012","unstructured":"Amaral LM, Palei AC, Sandrim VC, Luizon MR, Cavalli RC, Duarte G, et al. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy. J Hum Hypertens. 2012;26(9):547\u201352. doi:\n                      10.1038\/jhh.2011.65\n                      \n                    .","journal-title":"J Hum Hypertens"},{"key":"757_CR15","doi-asserted-by":"publisher","unstructured":"\u2022 Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005;46(6):1243-9. doi:\n                      10.1161\/01.HYP.0000188408.49896.c5\n                      \n                    . The review highlights valuable insights into pathophysiology that could guide ongoing clinical trials.","DOI":"10.1161\/01.HYP.0000188408.49896.c5"},{"issue":"6","key":"757_CR16","doi-asserted-by":"publisher","first-page":"R989","DOI":"10.1152\/ajpregu.00157.2004","volume":"286","author":"JP Granger","year":"2004","unstructured":"Granger JP. Inflammatory cytokines, vascular function, and hypertension. American journal of physiology. Regulatory, integrative and comparative physiology. 2004;286(6):R989\u201390. doi:\n                      10.1152\/ajpregu.00157.2004\n                      \n                    .","journal-title":"American journal of physiology. Regulatory, integrative and comparative physiology"},{"issue":"3","key":"757_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.mn.7800137","volume":"9","author":"JP Granger","year":"2002","unstructured":"Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia\/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147\u201360. doi:\n                      10.1038\/sj.mn.7800137\n                      \n                    .","journal-title":"Microcirculation"},{"issue":"3","key":"757_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406010465","volume":"8","author":"S Sankaralingam","year":"2006","unstructured":"Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med. 2006;8(3):1\u201320. doi:\n                      10.1017\/S1462399406010465\n                      \n                    .","journal-title":"Expert Rev Mol Med"},{"issue":"6","key":"757_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1600-0897.2010.00831.x","volume":"63","author":"CW Redman","year":"2010","unstructured":"Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol. 2010;63(6):534\u201343. doi:\n                      10.1111\/j.1600-0897.2010.00831.x\n                      \n                    .","journal-title":"Am J Reprod Immunol"},{"key":"757_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1152\/physiol.00006.2013","volume":"28","author":"B Lamarca","year":"2013","unstructured":"Lamarca B, Cornelius D, Wallace K. Elucidating immune mechanisms causing hypertension during pregnancy. Physiology. 2013;28:225\u201333.","journal-title":"Physiology"},{"issue":"5","key":"757_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","volume":"11","author":"A Borzychowski","year":"2006","unstructured":"Borzychowski A, Sargent I, Redman C. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11(5):309\u201316.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"757_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s11906-007-0088-1","volume":"9","author":"BD LaMarca","year":"2007","unstructured":"LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep. 2007;9(6):480\u20135.","journal-title":"Curr Hypertens Rep"},{"key":"757_CR23","doi-asserted-by":"publisher","unstructured":"\u2022 Murphy SR, LaMarca BB, Cockrell K, Granger JP. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension. 2010;55(2):394\u20138. doi:\n                      10.1161\/HYPERTENSIONAHA.109.141473\n                      \n                    . The study shows the important role of sFlt-1 to induce PE-like syndrome through nitric oxide and endothelin-1 pathways.","DOI":"10.1161\/HYPERTENSIONAHA.109.141473"},{"issue":"2","key":"757_CR24","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1152\/ajpregu.00069.2012","volume":"304","author":"SR Murphy","year":"2013","unstructured":"Murphy SR, LaMarca BB, Parrish M, Cockrell K, Granger JP. Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia\/hypoxia: role of tumor necrosis factor-alpha. American journal of physiology. Regulatory, integrative and comparative physiology. 2013;304(2):R130\u20135. doi:\n                      10.1152\/ajpregu.00069.2012\n                      \n                    .","journal-title":"American journal of physiology. Regulatory, integrative and comparative physiology."},{"issue":"5","key":"757_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649\u201358. doi:\n                      10.1172\/JCI17189\n                      \n                    .","journal-title":"J Clin Invest"},{"issue":"6","key":"757_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.semnephrol.2004.07.006","volume":"24","author":"R Dechend","year":"2004","unstructured":"Dechend R, Muller D, Wallukat G, Homuth V, Krause M, Dudenhausen J, et al. AT1 receptor agonistic antibodies, hypertension, and preeclampsia. Semin Nephrol. 2004;24(6):571\u20139.","journal-title":"Semin Nephrol"},{"key":"757_CR27","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 LaMarca B, Wallace K, Granger J. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Current Opinions in Pharmacology. 2011;11(2):175\u20139. This review discusses the potential role of the AT1-AA in mediating hypertension during pregnancy.","DOI":"10.1016\/j.coph.2011.01.003"},{"issue":"3","key":"757_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.HYP.0000116220.39793.c9","volume":"43","author":"M Noris","year":"2004","unstructured":"Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, et al. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension. 2004;43(3):614\u201322. doi:\n                      10.1161\/01.HYP.0000116220.39793.c9\n                      \n                    .","journal-title":"Hypertension"},{"key":"757_CR29","doi-asserted-by":"publisher","unstructured":"Eleuterio NM, Palei AC, Rangel Machado JS, Tanus-Santos JE, Cavalli RC, Sandrim VC. Relationship between adiponectin and nitrite in healthy and preeclampsia pregnancies. Clinica chimica acta; international journal of clinical chemistry. 2013;423:112\u20135. doi:\n                      10.1016\/j.cca.2013.04.027\n                      \n                    .","DOI":"10.1016\/j.cca.2013.04.027"},{"key":"757_CR30","doi-asserted-by":"publisher","unstructured":"Sandrim VC, Palei AC, Metzger IF, Cavalli RC, Duarte G, Tanus-Santos JE. Interethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsia. Clinica chimica acta; international journal of clinical chemistry. 2010;411(19\u201320):1457\u201360. doi:\n                      10.1016\/j.cca.2010.05.039\n                      \n                    .","DOI":"10.1016\/j.cca.2010.05.039"},{"issue":"2","key":"757_CR31","doi-asserted-by":"publisher","first-page":"R259","DOI":"10.1152\/ajpregu.00319.2011","volume":"302","author":"SR Murphy","year":"2012","unstructured":"Murphy SR, LaMarca B, Cockrell K, Arany M, Granger JP. L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. American journal of physiology. Regulatory, integrative and comparative physiology. 2012;302(2):R259\u201363. doi:\n                      10.1152\/ajpregu.00319.2011\n                      \n                    .","journal-title":"American journal of physiology. Regulatory, integrative and comparative physiology."},{"key":"757_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fimmu.2014.00244","volume":"5","author":"A Perez-Sepulveda","year":"2014","unstructured":"Perez-Sepulveda A, Torres M, Khoury M, Illanes S. Innate immune system and preeclampsia. Front Immunol. 2014;5:244.","journal-title":"Front Immunol"},{"issue":"4","key":"757_CR33","doi-asserted-by":"publisher","first-page":"R353","DOI":"10.1152\/ajpregu.00051.2012","volume":"303","author":"P Dhillion","year":"2012","unstructured":"Dhillion P, Wallace K, Scott J, Herse F, Heath J, Moseley J, et al. IL-17 mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2012;303(4):R353\u2013R8.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"757_CR34","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1016\/j.genm.2008.03.013","volume":"5","author":"B LaMarca","year":"2008","unstructured":"LaMarca B, Alexander B, Gilbert J, Ryan M, Sedeek M, Murphy S, et al. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gender Medicine. 2008;5:S133\u2013S8.","journal-title":"Gender Medicine"},{"issue":"2","key":"757_CR35","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1152\/ajpregu.00049.2012","volume":"303","author":"K Wallace","year":"2012","unstructured":"Wallace K, Novotny S, Heath J, Moseley J, Martin J, Owens M, et al. Hypertension in response to CD4+ T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol. 2012;303(2):R144\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"757_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1161\/01.HYP.0000141085.98320.01","volume":"44","author":"M Raijmakers","year":"2004","unstructured":"Raijmakers M, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44:374\u201380.","journal-title":"Hypertension"},{"issue":"7","key":"757_CR37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1053\/plac.2000.0560","volume":"21","author":"C Redman","year":"2000","unstructured":"Redman C, Sargent I. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21(7):597\u2013602.","journal-title":"Placenta"},{"issue":"5","key":"757_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1161\/HYPERTENSIONAHA.114.03590","volume":"64","author":"K Wallace","year":"2014","unstructured":"Wallace K, Cornelius D, Scott J, Heath J, Moseley J, Chatman K, et al. CD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemia. Hypertension. 2014;64(5):1151\u20138. doi:\n                      10.1161\/HYPERTENSIONAHA.114.03590\n                      \n                    .","journal-title":"Hypertension"},{"issue":"10","key":"757_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tem.2007.09.003","volume":"18","author":"S Walsh","year":"2007","unstructured":"Walsh S. Obesity: a risk factor for preeclampsia. Trends in Endocrinology & Metabolism. 2007;18(10):365\u201370.","journal-title":"Trends in Endocrinology & Metabolism"},{"issue":"11","key":"757_CR40","doi-asserted-by":"publisher","first-page":"R1326","DOI":"10.1152\/ajpregu.00178.2015","volume":"309","author":"F Spradley","year":"2015","unstructured":"Spradley F, Palei A, Granger J. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol. 2015;309(11):R1326\u201343.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"3","key":"757_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174399","volume":"12","author":"P Villa","year":"2017","unstructured":"Villa P, Marttinen P, Gillberg J, Lokki A, Majander K, Orden M, et al. Cluster analysis to estimate the risk of preeclampsia in the high-risk prediction and prevention of preeclampsia and intrauterine growth restriction (PREDO) study. PLoS One. 2017;12(3):e0174399.","journal-title":"PLoS One"},{"key":"757_CR42","doi-asserted-by":"crossref","unstructured":"Bartsch E, Medcalf K, Park A, Ray J, Group HRoP-eI. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.","DOI":"10.1136\/bmj.i1753"},{"key":"757_CR43","first-page":"3142","volume":"5","author":"F Spradley","year":"2015","unstructured":"Spradley F, Palei A, Granger J. Immune mechanisms linking obesity and preeclampsia. Biomol Ther. 2015;5:3142\u201376.","journal-title":"Biomol Ther"},{"issue":"7","key":"757_CR44","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.metabol.2007.03.008","volume":"56","author":"J Womack","year":"2007","unstructured":"Womack J, Tien P, Feldman J, Shin J, Fennie K, Anastos K, et al. Obesity and immune cell counts in women. Metabolism. 2007;56(7):998\u20131004.","journal-title":"Metabolism"},{"issue":"6","key":"757_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1095\/biolreprod.113.116186","volume":"90","author":"I Aye","year":"2014","unstructured":"Aye I, Lager S, Ramirez V, Gaccioli F, Dudley D, Jasson T, et al. Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol Reprod. 2014;90(6):129.","journal-title":"Biol Reprod"},{"issue":"3","key":"757_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00404-010-1753-1","volume":"283","author":"A Zavalza-Gomez","year":"2011","unstructured":"Zavalza-Gomez A. Obesity and oxidative stress: a direct link to preeclampsia? Arch Gyneccol Obstet. 2011;283(3):415\u201322.","journal-title":"Arch Gyneccol Obstet."},{"key":"757_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.placenta.2014.01.003","volume":"35","author":"J Saben","year":"2014","unstructured":"Saben J, Lindsey F, Zhong Y, Thakali K, Badger T, Andres A, et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta. 2014;35:171\u20137.","journal-title":"Placenta"},{"issue":"2","key":"757_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/10641955.2015.1115063","volume":"35","author":"R Costa","year":"2016","unstructured":"Costa R, Hoshida M, Alves E, Zugaib M, Francisco R. Preeclampsia and superimposed preeclampsia: the same disease? The role of angiogenic biomarkers. Hypertension in Pregnancy. 2016;35(2):139\u201349.","journal-title":"Hypertension in Pregnancy"},{"issue":"12","key":"757_CR49","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","volume":"27","author":"D Jensen","year":"2004","unstructured":"Jensen D, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard J, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27(12):2819\u201323.","journal-title":"Diabetes Care"},{"key":"757_CR50","doi-asserted-by":"crossref","unstructured":"Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32(11):2005\u20139.","DOI":"10.2337\/dc09-0656"},{"issue":"9\u201310","key":"757_CR51","first-page":"397","volume":"57","author":"K Knight","year":"2012","unstructured":"Knight K, Thornburg L, Pressman E. Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls. J Reprod Med. 2012;57(9\u201310):397\u2013404.","journal-title":"J Reprod Med"},{"key":"757_CR52","doi-asserted-by":"publisher","first-page":"361435","DOI":"10.1155\/2013\/361435","volume":"2013","author":"B Groen","year":"2013","unstructured":"Groen B, Links T, van den Berg P, Hellinga M, Moerman S, Visser G, et al. Similar adverse pregnancy outcome in native and nonnative Dutch women with pregestational type 2 diabetes: a multicentre retrospective study. ISRN Obstet Gynecol. 2013;2013:361435.","journal-title":"ISRN Obstet Gynecol"},{"issue":"3","key":"757_CR53","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s11892-015-0579-4","volume":"15","author":"T Weissgerber","year":"2015","unstructured":"Weissgerber T, Mudd L. Preeclampsia and diabetes. Curr Diab Rep. 2015;15(3):579.","journal-title":"Curr Diab Rep"},{"key":"757_CR54","doi-asserted-by":"publisher","first-page":"2846570","DOI":"10.1155\/2016\/2846570","volume":"2016","author":"C Nunemaker","year":"2016","unstructured":"Nunemaker C. Considerations for defining cytokine dose, duration and milieu that are appropriate for modeling chronic low-grade inflammation in type 2 diabetes. J Diabetes Res. 2016;2016:2846570.","journal-title":"J Diabetes Res"},{"issue":"2","key":"757_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jri.2009.04.009","volume":"82","author":"M Scioscia","year":"2009","unstructured":"Scioscia M, Gumaa K, Rademacher T. The link between insulin resistance and preeclampsia: new perspective. J Reprod Immunol. 2009;82(2):100\u20135.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"757_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00404-014-3220-x","volume":"290","author":"M Guimaraes","year":"2014","unstructured":"Guimaraes M, Brandao A, Rezende C, Cabral A, Brum A, Leite H, et al. Assessment of endothelial function in pregnant women with pre-eclampsia and gestational diabetes mellitus by flow-mediated dilation of brachial artery. Arch Gyneccol Obstet. 2014;290(3):441\u20137.","journal-title":"Arch Gyneccol Obstet"},{"issue":"5","key":"757_CR57","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cytogfr.2013.05.008","volume":"24","author":"E Conti","year":"2013","unstructured":"Conti E, Zezza L, Ralli E, Caserta D, Musumeci M, Moscarini M, et al. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards? Cytokine Growth Factor Rev. 2013;24(5):411\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"757_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.diabres.2010.04.015","volume":"89","author":"O Karacay","year":"2010","unstructured":"Karacay O, Sepici-Dincel A, Karcaaltincaba D, Sahin D, Yalvac S, Akyol M, et al. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-36 weeks gestation. Diabetes Res Clin Pract. 2010;89(3):231\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"S9","key":"757_CR59","first-page":"S263","volume":"54","author":"M Clowse","year":"2006","unstructured":"Clowse M, Jamison M, Myers E, James A. National study of medical complications in SLE pregnancies. Arthritis Rheum. 2006;54(S9):S263.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"757_CR60","first-page":"2127","volume":"30","author":"C Clark","year":"2003","unstructured":"Clark C, Spitzer K, Nadler J, Laskin C. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30(10):2127\u201332.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"757_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0897.2011.01049.x","volume":"66","author":"J Emerudh","year":"2011","unstructured":"Emerudh J, Berg G, Mjosberg J. Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance. Am J Reprod Immunol. 2011;66(Suppl 1):31\u201343.","journal-title":"Am J Reprod Immunol"},{"issue":"8","key":"757_CR62","doi-asserted-by":"publisher","first-page":"R884","DOI":"10.1152\/ajpregu.00154.2015","volume":"309","author":"D Cornelius","year":"2015","unstructured":"Cornelius D, Amaral L, Harmon A, Wallace K, Thomas A, Campbell N, et al. An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2015;309(8):R884\u2013R91.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"757_CR63","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/10641950802601237","volume":"28","author":"J Prins","year":"2009","unstructured":"Prins J, Boelens H, Heimweg J, Van der Heide S, Dubois A, Van Oosterhout A, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertension in Pregnancy. 2009;28:300\u201311.","journal-title":"Hypertension in Pregnancy."},{"key":"757_CR64","doi-asserted-by":"crossref","unstructured":"Gluhovschi C, Gluhovschi G, Petrica L, Velciov S, Gluhovschi A. Pregnancy associated with systemic lupus wrythematosus: immune tolerance in pregnancy and its deficiency in systemic lupus erythematosus\u2014an immunological dilemma. J Immunol Res. 2015;2015(241547).","DOI":"10.1155\/2015\/241547"},{"key":"757_CR65","doi-asserted-by":"publisher","first-page":"812138","DOI":"10.1155\/2012\/812138","volume":"2012","author":"Z Ulcova-Gallova","year":"2012","unstructured":"Ulcova-Gallova Z, Mockova A, Cedikova M. Screening tests of reproductive immunology in systemic lupus erythematosus. Autoimmune Diseases. 2012;2012:812138.","journal-title":"Autoimmune Diseases"},{"issue":"3\u20134","key":"757_CR66","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1600-0897.1992.tb00791.x","volume":"28","author":"J Hayslett","year":"1992","unstructured":"Hayslett J. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am J Reprod Immunol. 1992;28(3\u20134):199\u2013204.","journal-title":"Am J Reprod Immunol"},{"key":"757_CR67","doi-asserted-by":"crossref","unstructured":"\u2022 Guillemette L, Lacroix M, Allard C, Patenaude J, Battista M, Doyon M et al. Preeclampsia is associated with an increased pro-inflammatory profile in newborns. J Reprod Immunol. 2015;112:111-4. The study shows that newborns from mothers diagnosed with PE have higher levels of TNF\u03b1 at birth.","DOI":"10.1016\/j.jri.2015.09.003"},{"key":"757_CR68","doi-asserted-by":"crossref","unstructured":"\u2022 Nomura Y, John R, Janssen A, Davey C, Finik J, Buthmann J et al. Neurodevelopmental consequences in offspring of mothers with preeclampsia during pregnancy: underlying biological mechanism via imprinting genes. Arch Gyneccol Obstet. 2017;295(6):1319-29. This recent review attempts to show new evidence for imprinting gene dysregulation caused by hypertension and that could explain the link between preeclampsia and neurocognitive problems in offspring.","DOI":"10.1007\/s00404-017-4347-3"},{"issue":"4","key":"757_CR69","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.semperi.2013.04.007","volume":"37","author":"GT Too","year":"2013","unstructured":"Too GT, Hill JB. Hypertensive crisis during pregnancy and postpartum period. Semin Perinatol. 2013;37(4):280\u20137. doi:\n                      10.1053\/j.semperi.2013.04.007\n                      \n                    .","journal-title":"Semin Perinatol"},{"key":"757_CR70","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Owens MY, Martin JN, Jr., Wallace K, Keiser SD, Parrish MR, Tam Tam KB et al. Postpartum thrombotic microangiopathic syndrome. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis. 2013;48(1):51-7. doi:10.1016\/j.transci.2012.05.016. This study reports an important patient case and discusses about the early recognition of thrombotic thrombocytopenic purpura for the appropriate treatment.","DOI":"10.1016\/j.transci.2012.05.016"},{"key":"757_CR71","doi-asserted-by":"publisher","unstructured":"Committee on Obstetric P. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2015;125(2):521\u2013525. doi:\n                      10.1097\/01.AOG.0000460762.59152.d7\n                      \n                    .","DOI":"10.1097\/01.AOG.0000460762.59152.d7"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-017-0757-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-017-0757-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-017-0757-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:56:31Z","timestamp":1589734591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-017-0757-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s11906-017-0757-7","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,8]]},"assertion":[{"value":"8 July 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"61"}}